Fierce Healthcare Names Atropos Health a “Fierce 15” Company of 2026

Audio By Carbonatix

PALO ALTO, Calif.--(BUSINESS WIRE)--Mar 9, 2026--

Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE), today announced that Fierce Healthcare has named it as one of 2026’s “Fierce 15” healthcare companies. The annual special report features the most innovative private healthcare companies looking to change the face of the industry.

“Real-world evidence is more critical than ever when it comes to making decisions for personalized patient care and precision medicine,” said Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health. “Physicians and researchers rely on our solutions to generate new evidence from real-world clinical settings when those answers don't exist in published literature. We’re honored to be recognized by Fierce Healthcare and remain focused on closing the evidence gap and advancing the delivery of data-driven care.”

Atropos Health advances the use of real-world evidence (RWE) to help health systems and life science companies close critical evidence gaps in medicine and accelerate drug discovery and development. ChatRWD®, the first healthcare-specific large language model purpose-built to query real-world clinical data at scale, answers clinical questions rapidly with evidence, enabling faster, more informed decision-making for clinicians and researchers. Building on this momentum, the company recently introduced a Commercial Analytics solution for life sciences organizations and the Atropos Evidence™ Agent, an expert RWE agent for healthcare that integrates within physician workflows.

"Over the past eight years, we have reviewed hundreds of private companies for potential inclusion in the 'Fierce 15' special report. The selection draws from diverse sectors across the industry, from primary care to health technology. Year after year, these honorees remind us that the future of healthcare is being built right now, and this special report is our way of showcasing their innovative work and honoring their impact," said Ayla Ellison, Editor-in-Chief, Fierce Life Sciences and Healthcare.

About Fierce Healthcare

Fierce Healthcare delivers healthcare news at the intersection of business and policy. Our journalists strive to bring our readers breaking industry news, exclusive interviews and thoughtfully-reported stories that offer a deeper insight on how changes in the industry impact their corner of the healthcare world. Our family includes Fierce Healthcare, Fierce Health Payer, Fierce Health Tech, Fierce Hospitals and Fierce Health Finance. Click here to subscribe to one or all of our newsletters.

About Atropos Health

Atropos Health is the developer of GENEVA OS®, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improve individual patient outcomes with data-driven care, and expedite research that advances the field of medicine. We aim to transform healthcare with timely, relevant, real-world evidence.

To learn more about Atropos Health, visit www.atroposhealth.com or connect through LinkedIn or X (Twitter).

View source version on businesswire.com:https://www.businesswire.com/news/home/20260309966082/en/

CONTACT: Media Contact

Evan Scarduffa

[email protected]

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: TECHNOLOGY BIOTECHNOLOGY HEALTH OTHER HEALTH PHARMACEUTICAL OTHER SCIENCE PRACTICE MANAGEMENT SOFTWARE MANAGED CARE NETWORKS GENERAL HEALTH HEALTH TECHNOLOGY SCIENCE DATA MANAGEMENT

SOURCE: Atropos Health

Copyright Business Wire 2026.

PUB: 03/09/2026 09:00 AM/DISC: 03/09/2026 09:00 AM

http://www.businesswire.com/news/home/20260309966082/en